EFMC
IONS icon

Empire Financial Management Company’s Ionis Pharmaceuticals IONS Stock Holding History

Empire Financial Management Company’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,000
Closed -$523K – 216
2025
Q3 		$523K Buy
+8,000
New +$391K 0.12% 151

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Empire Financial Management Company's IONS Position: Q4 2025 in Review

Empire Financial Management Company sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 8,000 shares — an estimated $523K sold.

Empire Financial Management Company first reported a position in IONS in Q3 2025 and held it in 1 quarter. The position peaked at $523K in Q3 2025. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • Empire Financial Management Company reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Empire Financial Management Company sold 8,000 Ionis Pharmaceuticals shares in Q4 2025, an estimated $523K.
  • Empire Financial Management Company first reported a position in Ionis Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Empire Financial Management Company's Ionis Pharmaceuticals position peaked at $523K in Q3 2025.
  • 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Empire Financial Management Company's 13F filing for Q4 2025, filed 12 Feb 2026.